Add BrightSurf on Google Email

Johns Hopkins Medicine


Nanofiber coating prevents infections of prosthetic joints

A novel nanofiber coating with antibiotic-releasing properties has shown promise in preventing serious bacterial infections related to total joint replacement surgery. The coating was found to completely eradicate infection and prevent bone loss, a common complication that leads to prosthetic loosening and failure.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateOct 24, 2016

Hopping around Johns Hopkins: Early mobilization program, PICU Up!, gets pediatrics patients moving

A Johns Hopkins pilot program proves safe and effective in reducing sedation and boosting early mobility for children in intensive care units. The PICU Up! Early Rehabilitation and Progressive Mobility Program includes activities such as sitting, standing, and walking, resulting in increased rates of physical therapy consultations and ...

SourceJohns Hopkins Medicine·JournalPediatric Critical Care Medicine·DateOct 13, 2016

Brain cell 'executioner' identified

Scientists at Johns Hopkins Medicine have identified a protein called macrophage migration inhibitory factor (MIF) as the final execution step in parthanatos, a form of programmed brain cell death. MIF's ability has been linked to stroke but also may be involved in other neurodegenerative diseases.

SourceJohns Hopkins Medicine·JournalScience·DateOct 6, 2016

Assessing the intangible

Researchers developed a checklist to measure respect and dignity in ICUs, identifying differences between ICU types with distinct patient populations. The study found significant correlations between clinician behavior and patient outcomes, highlighting the importance of respectful care.

SourceJohns Hopkins Medicine·JournalCritical Care Medicine·DateOct 3, 2016

Johns Hopkins scientists track metabolic pathways to find drug combination for pancreatic cancer

Scientists at Johns Hopkins have discovered a drug combination that specifically targets the metabolic pathways of pancreatic cancer cells. By combining an experimental drug with metformin, researchers were able to shrink tumors by at least 50% in animal models, providing new evidence for treating this aggressive form of cancer.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateAug 24, 2016

Severe obesity revealed as a stand-alone high-risk factor for heart failure

A Johns Hopkins study of over 13,000 participants found that severe obesity is a standalone high-risk factor for heart failure, but not other types of heart disease. Morbidly obese individuals were nearly fourfold more likely to develop heart failure even after controlling for risk factors such as high blood pressure and diabetes.

SourceJohns Hopkins Medicine·JournalJournal of the American Heart Association·DateAug 22, 2016

To beat hypertension, take the 'clinic' to the people

A new study from Johns Hopkins Medicine found that one-on-one coaching sessions with trained pharmacists and dietitians significantly reduced blood pressure among participants, especially those who were African American. The program's motivational interviewing approach helped patients set achievable goals and address medication concerns.

SourceJohns Hopkins Medicine·JournalEthnicity & Disease·DateAug 4, 2016

Ovarian cancer study uncovers new biology

A recent study has identified over 200 proteins involved in cell movement and immune system function that are implicated in ovarian cancer progression. By analyzing the proteomes of 169 ovarian cancer patients, researchers have gained new insights into the biology of the disease and potential targets for treatment.

SourceJohns Hopkins Medicine·JournalCell·DateJun 29, 2016

Blocking key enzyme halts Parkinson's disease symptoms in mice

Researchers at Johns Hopkins Medicine discovered that blocking the enzyme c-Abl prevents Parkinson's disease symptoms in specially bred mice. The study also found that a chemical tag on the protein α-synuclein may signal the disorder's presence and progression. The findings suggest both a promising target for drug research and a potent...

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateJun 27, 2016